Windlas Biotech Ltd released its investor presentation detailing financial results for the quarter and half-year ending September 30, 2025, highlighting a 5-year CAGR of 18% revenue and a net debt-free position with Rs 213 Cr liquidity.
AI Assistant
Windlas Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.